Pakistan Has Secured 17.5 Million Doses of Coronavirus Vaccine

Pakistan has secured 17 million doses of AstraZeneca’s Coronavirus vaccine through COVAX in addition to the 0.5 million doses of Sinopharm’s vaccine.

Around 7 million of these doses will be made available by March while the remaining will be received and distributed in Q2 2021.


Bilquis Edhi Declared ‘Person of the Decade’ by Impact Hallmarks

According to SAPM on Health, Dr. Faisal Sultan, the country-wide Coronavirus vaccination campaign will kick off next week, beginning with frontline healthcare workers.

Dr. Faisal added that COVAX’s timely support and delivery of the Coronavirus vaccine is a testament of global stakeholders’ trust in Pakistan’s preparedness for vaccine roll-out.

He expressed confidence in meeting the targets of the large-scale countrywide immunization campaign over the coming months this year.


UAE Will Now Grant Citizenship to Foreign Investors, Doctors

Earlier today, Dr. Faisal said that the first batch comprising of 0.5 million doses of the Sinopharm vaccine has reached Pakistan.

So far, the Drug Regulatory Authority of Pakistan (DRAP) has approved three coronavirus vaccines including the Oxford-AstraZeneca vaccine, the vaccine developed by the Chinese state-owned firm, China National Pharmaceutical Group (Sinopharm), and Russian-developed Sputnik V.